ONCOGEN PHARMA FDA Approval ANDA 215947

ANDA 215947

ONCOGEN PHARMA

FDA Drug Application

Application #215947

Application Sponsors

ANDA 215947ONCOGEN PHARMA

Marketing Status

Prescription001
Prescription002

Application Products

001TABLET;ORAL250MG0ABIRATERONE ACETATEABIRATERONE ACETATE
002TABLET;ORAL500MG0ABIRATERONE ACETATEABIRATERONE ACETATE

FDA Submissions

UNKNOWN; ORIG1AP2022-01-05STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

ONCOGEN PHARMA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 215947
            [companyName] => ONCOGEN PHARMA
            [docInserts] => ["",""]
            [products] => [{"drugName":"ABIRATERONE ACETATE","activeIngredients":"ABIRATERONE ACETATE","strength":"250MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"ABIRATERONE ACETATE","activeIngredients":"ABIRATERONE ACETATE","strength":"500MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"01\/05\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-01-05
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.